Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation

Gordon J. Freeman(Dana-Farber Cancer Institute), John G. Gribben(Dana-Farber Cancer Institute), Vassiliki A. Boussiotis(Dana-Farber Cancer Institute), Judy W. Ng(Dana-Farber Cancer Institute), Vincent A. Restivo(Dana-Farber Cancer Institute), Lisa A. Lombard(Dana-Farber Cancer Institute), Gary S. Gray(Repligen (United States)), Lee M. Nadler(Dana-Farber Cancer Institute)
Science
November 5, 1993
Cited by 914

Abstract

Although presentation of antigen to the T cell receptor is necessary for the initiation of an immune response, additional molecules expressed on antigen-presenting cells deliver essential costimulatory signals. T cell activation, in the absence of costimulation, results in T cell anergy. The B7-1 protein is a costimulator molecule that regulates interleukin-2 (IL-2) secretion by signaling through the pathway that uses CD28 and CTLA-4 (hereafter referred to as the CD28 pathway). We have cloned a counter-receptor of CD28 and CTLA-4, termed B7-2. Although only 26 percent identical to B7-1, B7-2 also costimulates IL-2 production and T cell proliferation. Unlike B7-1, B7-2 messenger RNA is constitutively expressed in unstimulated B cells. It is likely that B7-2 provides a critical early costimulatory signal determining if the T cell will contribute to an immune response or become anergic.


Related Papers

No related papers found

Powered by citation graph analysis